Program Committee Members
Judith Beizer, PharmD, AGS President-elect
Nicole J. Brandt, PharmD, MBA
Cynthia Boyd, MD
Lenise Cummings-Vaughan, MD
Ellen Flaherty, PhD
Annie Medina-Walpole, MD, PEEC Chair
Alison Moore, MD, AGS President
Ugochi Ohuabunwa, MD
James T. Pacala, MD, MS
Joseph Shega, MD
Liron Sinvani, MD
Camille Vaughan, MD, 2027 AGS Annual Scientific Meeting Chair
Disclosure of Relationships with Ineligible Companies
As an ACCME accredited provider of Continuing Medical Education, the American Geriatrics Society must ensure balance, independence, objectivity and scientific rigor in all of our educational activities. We have implemented a process wherein everyone who is in a position to control the content of an education activity has disclosed to us all financial relationships with any ineligible company within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. AGS then reviews the disclosure information to determine which financial relationships are relevant and mitigates relevant financial relationships with ineligible companies to prevent commercial bias in the content.
| Committee Member | Disclosure |
| Judith Beizer, PharmD | No financial relationships with ineligible companies. |
| Cynthia Boyd, MD | No financial relationships with ineligible companies. |
| Nicole J. Brandt, PharmD, MBA | No financial relationships with ineligible companies. |
| Lenise Cummings-Vaughan, MD | No financial relationships with ineligible companies. |
| Ellen Flaherty, PhD, APRN, BC | No financial relationships with ineligible companies. |
| Annie Medina-Walpole, MD | No financial relationships with ineligible companies. |
| Alison Moore, MD | No financial relationships with ineligible companies. |
| Ugochi Ohuabunwa, MD | No financial relationships with ineligible companies. |
| James T. Pacala, MD, MS | No financial relationships with ineligible companies. |
| Joseph Shega, MD | No financial relationships with ineligible companies. |
| Liron Sinvani, MD | No financial relationships with ineligible companies. |
| Camille Vaughan, MD | No financial relationships with ineligible companies. |